Preoperative Immunocyte-Derived Ratios Predict Postoperative Recovery of Gastrointestinal Motility after Colorectal Cancer Surgery.
bowel function
colorectal neoplasms
ileus
inflammation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
03 Oct 2023
03 Oct 2023
Historique:
received:
22
06
2023
revised:
20
08
2023
accepted:
30
09
2023
medline:
14
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
The aim of this study was to assess the role of immunocyte-derived ratios (IDRs), such as the systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR), as markers for the postoperative recovery of gastrointestinal function following colorectal cancer surgery. A retrospective analysis was conducted on a consecutive cohort of 260 patients who underwent radical colorectal cancer surgery within the timeframe spanning from January 2016 to December 2022. Data concerning the postoperative recovery of gastrointestinal function included the I-FEED score, time to pass flatus, toleration for liquids in the first 48 h, and the need for nasogastric tube reinsertion in the immediate postoperative period. A special emphasis was allocated towards the examination of IDRs and their interrelation with the postoperative gastrointestinal functional parameters. The I-FEED score exhibited a positive correlation with the NLR, SII, and PLR. The univariate analysis indicated that all IDRs, multiorgan resection, hemoglobin and protein levels, regional nodal extent of the tumor (N), and obesity significantly affected nasogastric tube reinsertion. The multivariate analysis showed that the SII and N1 stages were risk factors for nasogastric tube reinsertion after colorectal cancer surgery. The SII and multiorgan resection were the only classifiers that remained significant in the multivariable analysis for the toleration for liquids. In summation, certain preoperative IDRs, such as the SII, PLR, and NLR, may hold potential as predictive determinants for postoperative gastrointestinal functional recovery following colorectal cancer surgery.
Identifiants
pubmed: 37834982
pii: jcm12196338
doi: 10.3390/jcm12196338
pmc: PMC10573957
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cochrane Database Syst Rev. 2016 Jul 16;7:CD001893
pubmed: 27419911
J Gastrointest Surg. 2020 Sep;24(9):2160-2166
pubmed: 32524361
Biomed Pharmacother. 2022 Dec;156:113922
pubmed: 36411615
J Gastrointest Surg. 2013 May;17(5):962-72
pubmed: 23377782
Am J Health Syst Pharm. 2007 Oct 15;64(20 Suppl 13):S3-7
pubmed: 17909274
World J Gastroenterol. 2020 Mar 21;26(11):1185-1196
pubmed: 32231422
J Transl Med. 2023 May 26;21(1):349
pubmed: 37237321
Surg Today. 2018 Oct;48(10):936-943
pubmed: 29774420
J Smooth Muscle Res. 2013;49:99-111
pubmed: 24662475
Surg Today. 2007;37(12):1023-32
pubmed: 18030561
J Neurogastroenterol Motil. 2022 Oct 30;28(4):517-530
pubmed: 36250359
Front Physiol. 2023 May 18;14:1174655
pubmed: 37275228
Neurogastroenterol Motil. 2023 Jun 8;:e14618
pubmed: 37288650
J Gastrointest Surg. 2023 Aug;27(8):1730-1745
pubmed: 37277676
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Colorectal Dis. 2023 Mar 11;38(1):68
pubmed: 36899148
Anesth Analg. 2018 Jun;126(6):1896-1907
pubmed: 29293183
J Manag Care Pharm. 2009 Jul-Aug;15(6):485-94
pubmed: 19610681
Int J Clin Oncol. 2022 Nov;27(11):1706-1716
pubmed: 35951171
J Laparoendosc Adv Surg Tech A. 2023 Jun;33(6):586-595
pubmed: 37130316
Medicine (Baltimore). 2023 Feb 3;102(5):e32735
pubmed: 36749238
Am Surg. 2022 Oct;88(10):2572-2578
pubmed: 35771192
Br J Surg. 2018 Jun;105(7):907-917
pubmed: 29656582
Cir Esp. 2016 Nov;94(9):495-501
pubmed: 27456544
Front Neurol. 2023 Jun 08;14:1174711
pubmed: 37360337
Curr Pharm Des. 2014;20(16):2775-82
pubmed: 23886379
Int J Mol Sci. 2022 Mar 26;23(7):
pubmed: 35408994
J Nippon Med Sch. 2019;86(3):142-148
pubmed: 31292325
Chin Med J (Engl). 2021 Nov 3;134(23):2865-2873
pubmed: 34732661
J Am Coll Surg. 2010 Feb;210(2):228-31
pubmed: 20113944
Surg Endosc. 2020 May;34(5):2219-2226
pubmed: 31363895
Int J Mol Sci. 2022 Jun 22;23(13):
pubmed: 35805922
Front Pharmacol. 2020 Nov 24;11:583422
pubmed: 33390950
Tech Coloproctol. 2023 May 15;:
pubmed: 37184771
Bratisl Lek Listy. 2021;122(7):474-488
pubmed: 34161115
Int J Surg. 2015 Feb;14:49-55
pubmed: 25576763
J Neurogastroenterol Motil. 2021 Oct 30;27(4):588-595
pubmed: 34642279
Ann Surg. 2014 Apr;259(4):708-14
pubmed: 23657087